TY  - JOUR

T1  - A novel fragment derived from the beta chain of human fibrinogen, beta43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo.

JO  - Br J Cancer

PY  - 2010/02/02

AU  - Krajewska E

AU  - Lewis CE

AU  - Chen Y-Y

AU  - Welford A

AU  - Tazzyman S

AU  - Staton CA

ED  - 

DO  - DOI: 10.1038/sj.bjc.6605495

VL  - 102

IS  - 3

SP  - 594

EP  - 601

Y2  - 2024/09/19

ER  -